


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+20.45%
+0.49%
-3.49%
+6.50%
+0.14%
VTEX
VTEX
$3.88
Strengths

Earnings are forecast to grow
VTEX Price Performance
$3.24 (+19.75%)
$3.88 (0.00%)
$4.22 (-8.06%)
$4.88 (-20.49%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
VTEX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VTEX Street Sentiment is extremely bullish and have positive views on the near-term outlook
VTEX has Medium risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Nov 11, 2025
Reiterate
Neutral
JP Morgan
What is VTEX current stock price?
What are VTEX stock strengths?
What is VTEX Risk Level?
What is VTEX market cap and volume?
What is VTEX current Stock IQ?
Should I buy VTEX stock right now?
Is VTEX a Strong Buy right now?
What does a 'Strong Buy' rating mean for VTEX?
What does a 'Strong Sell' rating mean for VTEX?
What factors influence VTEX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
VTEX
VTEX
Current Price
$3.88

VTEX Price Performance
$3.24 (+19.75%)
$3.88 (0.00%)
$4.22 (-8.06%)
$4.88 (-20.49%)
VTEX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
VTEX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VTEX Street Sentiment is extremely bullish and have positive views on the near-term outlook
VTEX has Medium risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
VTEX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
VTEX Latest Analysis
Vtex outlines mid- to high single-digit subscription revenue growth for 2026 while accelerating AI-driven transformation.
Fri Feb 27, 2026
Vtex GAAP EPS of $0.05 beats by $0.01 revenue of $68M misses by $0.11M.
Thu Feb 26, 2026
Novo bets up to $2.1B in Vivtex deal for oral obesity and diabetes drugs.
Wed Feb 25, 2026
Novo Partners with Biotech Vivtex to Boost Obesity Drug Pipeline. Novo Nordisk A/S will partner with US biotech firm Vivtex Corp. to develop next-generation drugs for obesity diabetes and other metabolic diseases in a deal potentially worth up to $2.1 billion.
Wed Feb 25, 2026
Novo Nordisk Partners Vivtex To Develop Next-generation Oral Medicines For Obesity And Diabetes . (RTTNews) - Danish drugmaker Novo Nordisk and biotechnology company Vivtex Corp. announced Wednesday a partnership to develop next-generation oral biologic medicines for obesity diabetes and associated comorbidities.
Wed Feb 25, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VTEX Stock trends
VTEX Stock performance
VTEX Stock analysis
VTEX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.